Sensitizing estrogen receptor-negative breast cancer cells to tamoxifen with OSU-03012, a novel celecoxib-derived phosphoinositide-dependent protein kinase-1/Akt signaling inhibitor.
- DOI
- 10.1158/1535-7163.mct-07-0434
- Published
- 2008 Apr
- Container
- Molecular cancer therapeutics
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
serious concern Score 8/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- serious concernRetraction Watch retraction: 1 retraction notice matched this DOI.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1158/1535-7163.mct-07-0434,
title = {Sensitizing estrogen receptor-negative breast cancer cells to tamoxifen with OSU-03012, a novel celecoxib-derived phosphoinositide-dependent protein kinase-1/Akt signaling inhibitor.},
author = {Weng SC and Kashida Y and Kulp SK and Wang D and Brueggemeier RW and Shapiro CL and Chen CS},
year = {2008},
journal = {Molecular cancer therapeutics},
doi = {10.1158/1535-7163.mct-07-0434},
url = {https://doi.org/10.1158/1535-7163.mct-07-0434}
}RIS
TY - JOUR TI - Sensitizing estrogen receptor-negative breast cancer cells to tamoxifen with OSU-03012, a novel celecoxib-derived phosphoinositide-dependent protein kinase-1/Akt signaling inhibitor. AU - Weng SC AU - Kashida Y AU - Kulp SK AU - Wang D AU - Brueggemeier RW AU - Shapiro CL AU - Chen CS PY - 2008 JO - Molecular cancer therapeutics DO - 10.1158/1535-7163.mct-07-0434 UR - https://doi.org/10.1158/1535-7163.mct-07-0434 ER -
APA
SC, W., Y, K., SK, K., D, W., RW, B., CL, S., & CS, C. (2008). Sensitizing estrogen receptor-negative breast cancer cells to tamoxifen with OSU-03012, a novel celecoxib-derived phosphoinositide-dependent protein kinase-1/Akt signaling inhibitor.. Molecular cancer therapeutics. https://doi.org/10.1158/1535-7163.mct-07-0434
Source records
- pubmed · retrieved 2026-09-26T05:11:08.773Z